Does ABATACEPT Cause Myelodysplastic syndrome? 33 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 33 reports of Myelodysplastic syndrome have been filed in association with ABATACEPT (ORENCIA). This represents 0.0% of all adverse event reports for ABATACEPT.
33
Reports of Myelodysplastic syndrome with ABATACEPT
0.0%
of all ABATACEPT reports
2
Deaths
21
Hospitalizations
How Dangerous Is Myelodysplastic syndrome From ABATACEPT?
Of the 33 reports, 2 (6.1%) resulted in death, 21 (63.6%) required hospitalization, and 1 (3.0%) were considered life-threatening.
Is Myelodysplastic syndrome Listed in the Official Label?
Yes, Myelodysplastic syndrome is listed as a known adverse reaction in the official FDA drug label for ABATACEPT.
What Other Side Effects Does ABATACEPT Cause?
Drug ineffective (35,212)
Rheumatoid arthritis (21,898)
Pain (19,783)
Arthralgia (18,536)
Joint swelling (18,453)
Contraindicated product administered (13,559)
Fatigue (13,087)
Drug intolerance (12,451)
Rash (12,168)
Arthropathy (11,099)
What Other Drugs Cause Myelodysplastic syndrome?
CYCLOPHOSPHAMIDE (1,545)
LENALIDOMIDE (1,285)
DOXORUBICIN (1,236)
RITUXIMAB (1,054)
VINCRISTINE (966)
ETOPOSIDE (936)
DEXAMETHASONE (759)
METHOTREXATE (728)
CYTARABINE (715)
CARBOPLATIN (698)
Which ABATACEPT Alternatives Have Lower Myelodysplastic syndrome Risk?
ABATACEPT vs ABATACEPT SUBQ /ML
ABATACEPT vs ABCIXIMAB
ABATACEPT vs ABEMACICLIB
ABATACEPT vs ABILIFY
ABATACEPT vs ABIRATERONE